    <IPython.core.display.Javascript object>


# COVID-19 Vaccine Development Tracker

Welcome to **covid-vaccine-tracker.com**. This website presents a summary of the data published by the WHO regarding the develipment of COVID-19 vaccines (https://www.who.int/blueprint/priority-diseases/key-action/novel-coronavirus-landscape-ncov.pdf?ua=1). No modifications have been made to the data, and it has been done as an attempt to make this information more easily accessible to the public. The website is updated on a daily basis.

### COVID-19 Vaccine Platforms in Development

    Got stderr: Mar 27, 2020 8:36:51 PM org.apache.pdfbox.pdmodel.font.PDCIDFontType2 <init>
    INFO: OpenType Layout tables used in font BCDGEE+Calibri-Light are not implemented in PDFBox and will be ignored
    Mar 27, 2020 8:36:52 PM org.apache.pdfbox.pdmodel.font.PDCIDFontType2 <init>
    INFO: OpenType Layout tables used in font BCDIEE+Calibri are not implemented in PDFBox and will be ignored
    


    findfont: Font family ['normal'] not found. Falling back to DejaVu Sans.
    findfont: Font family ['normal'] not found. Falling back to DejaVu Sans.



![png](Index_files/Index_5_1.png)


<pre>






</pre>



### Clincal Trial Phase


![png](Index_files/Index_7_0.png)


# Data

I have filtered the WHO data and made it more accessible. If you would like a spreadsheet version of this data, please email me at: *covid.vaccine.tracker@gmail.com*


    <IPython.core.display.Javascript object>





<div><table id="d3343ae9-59bb-41c9-afad-b73487fea24c" class="display"><thead>
    <tr style="text-align: right;">
      <th></th>
      <th>Vaccine Platform</th>
      <th>Vaccine Specifics</th>
      <th>Company 
 Developer</th>
      <th>Trial Stage</th>
      <th>Other Uses</th>
    </tr>
  </thead></table>
<script type="text/javascript">
require(["datatables"], function (datatables) {
    $(document).ready(function () {        
        var dt_args = {"columnDefs": [{"width": "70px", "targets": "_all"}], "data": [[0, "Non- Replicating Viral Vector", "Adenovirus Type 5 Vector", "CanSino Biological Inc. and Beijing Institute of Biotechnology", "Phase 1", "Ebola"], [1, "RNA", "LNP- encapsulated mRNA", "Moderna/NIAID", "Phase 1", "multiple candidates"], [6, "DNA", "DNA plasmid vaccine Electroporation device", "Inovio Pharmaceuticals", "Pre-Clinical", "Lassa, Nipah HIV Filovirus HPV Cancer indications Zika Hepatitis B"], [7, "DNA", "DNA", "Takis/Applied DNA Sciences/Evvivax", "Pre-Clinical", "nan"], [8, "DNA", "DNA plasmid vaccine", "Zydus Cadila", "Pre-Clinical", "nan"], [9, "Inactivated", "Formaldehyde- inactivated + alum", "Sinovac", "Pre-Clinical", "SARS"], [10, "Live Attenuated Virus", "Deoptimized live attanuated vaccines", "Codagenix/Serum Institute of India", "Pre-Clinical", "HAV, InfA, ZIKV, FMD, SIV, RSV, DENV"], [11, "Non- Replicating Viral Vector", "MVA encoded VLP", "GeoVax/BravoVax", "Pre-Clinical", "LASV, EBOV, MARV, HIV"], [12, "Non- Replicating Viral Vector", "Ad26 (alone or with MVA boost)", "Janssen Pharmaceutical Companies", "Pre-Clinical", "Ebola, HIV, RSV"], [13, "Non- Replicating Viral Vector", "ChAdOx1", "University of Oxford", "Pre-Clinical", "influenza, TB, Chikungunya, Zika, MenB, plague"], [14, "Non- Replicating Viral Vector", "adenovirus- based NasoVAX expressing SARS2-CoV spike protein", "Altimmune", "Pre-Clinical", "influenza"], [15, "Non- Replicating Viral Vector", "Ad5 S (GREVAXTM platform)", "Greffex", "Pre-Clinical", "MERS"], [16, "Non- Replicating Viral Vector", "Oral Vaccine platform", "Vaxart", "Pre-Clinical", "InfA, CHIKV, LASV, NORV; EBOV, RVF, HBV, VEE"], [17, "Protein Subunit", "Drosophila S2 insect cell expression system VLPs", "ExpreS2ion", "Pre-Clinical", "nan"], [18, "Protein Subunit", "S protein", "WRAIR/USAMRIID", "Pre-Clinical", "nan"], [19, "Protein Subunit", "S-Trimer", "Clover Biopharmaceuticals Inc./GSK", "Pre-Clinical", "HIV, REV Influenza"], [20, "Protein Subunit", "Peptide", "Vaxil Bio", "Pre-Clinical", "nan"], [21, "Protein Subunit", "S protein", "AJ Vaccines", "Pre-Clinical", "nan"], [22, "Protein Subunit", "Ii-Key peptide", "Generex/EpiVax", "Pre-Clinical", "Influenza, HIV, SARS- CoV"], [23, "Protein Subunit", "S protein", "EpiVax/Univ. of Georgia", "Pre-Clinical", "H7N9"], [24, "Protein Subunit", "S protein (baculovirus production)", "Sanofi Pasteur", "Pre-Clinical", "Influenza, SARS-CoV"], [25, "Protein Subunit", "Full length S trimers/ nanoparticle + Matrix M", "Novavax", "Pre-Clinical", "RSV; CCHF, HPV, VZV, EBOV"], [26, "Protein Subunit", "gp-96 backbone", "Heat Biologics/Univ. Of Miami", "Pre-Clinical", "NSCLC, HIV, malaria, Zika"], [27, "Protein Subunit", "Molecular clamp stabilized Spike protein", "University of Queensland/GSK", "Pre-Clinical", "Nipah, influenza, Ebola, Lassa"], [28, "Protein Subunit", "S1 or RBD protein", "Baylor College of Medicine", "Pre-Clinical", "SARS"], [29, "Protein Subunit", "Subunit protein, plant produced", "iBio/CC-Pharming", "Pre-Clinical", "nan"], [30, "Protein Subunit", "Subunit", "VIDO-InterVac, University of Saskatchewan", "Pre-Clinical", "nan"], [31, "Protein Subunit", "Adjuvanted microsphere peptide", "University of Saskatchewan", "Pre-Clinical", "nan"], [32, "Replicating Viral Vector", "Measles Vector", "Zydus Cadila", "Pre-Clinical", "nan"], [33, "Replicating Viral Vector", "Measles Vector", "Institute Pasteur/Themis/Univ. of Pittsburg Center for Vaccine Research", "Pre-Clinical", "West nile, chik, Ebola, Lassa, Zika"], [34, "Replicating Viral Vector", "Horsepox vector expressing S protein", "Tonix Pharma/Southern Research", "Pre-Clinical", "Smallpox, monkeypox"], [35, "RNA", "LNP- encapsulated mRNA  cocktail encoding VLP", "Fudan University/ Shanghai JiaoTong University/RNACure Biopharma", "Pre-Clinical", "nan"], [36, "RNA", "LNP- encapsulated mRNA encoding RBD", "Fudan University/ Shanghai JiaoTong University/RNACure Biopharma", "Pre-Clinical", "nan"], [37, "RNA", "mRNA", "China CDC/Tongji University/Stermina", "Pre-Clinical", "nan"], [38, "RNA", "mRNA", "Arcturus/Duke-NUS", "Pre-Clinical", "multiple candidates"], [39, "RNA", "mRNA", "BioNTech/Fosun Pharma/Pfizer", "Pre-Clinical", "nan"], [40, "RNA", "saRNA", "Imperial College London", "Pre-Clinical", "EBOV; LASV, MARV, Inf (H7N9), RABV"], [41, "RNA", "mRNA", "Curevac", "Pre-Clinical", "RABV, LASV, YFV; MERS, InfA, ZIKV, DengV, NIPV"], [42, "VLP", "Plant-derived VLP", "Medicago Inc.", "Pre-Clinical", "Flu, Rotavirus, Norovirus, West Nile virus, Cancer"], [43, "Unknown", "Unknown", "University of Hong Kong", "Pre-Clinical", "nan"], [44, "Unknown", "Unknown", "ImmunoPrecise", "Pre-Clinical", "nan"], [45, "Unknown", "Unknown", "MIGAL Galilee Research Institute", "Pre-Clinical", "nan"], [46, "Unknown", "Unknown", "Doherty Institute", "Pre-Clinical", "nan"], [47, "Unknown", "Unknown", "Tulane University", "Pre-Clinical", "nan"]]};
        dt_args = eval_functions(dt_args);
        table = $('#d3343ae9-59bb-41c9-afad-b73487fea24c').DataTable(dt_args);
    });
})
</script>
</div>




### Citation

Lucas, A. COVID-19 Vaccine Development Tracker. 27 Mar. 2020, covid-vaccine-tracker.com. DOI:10.5281/zenodo.3731761
